Effects of cardiopulmonary rehabilitation on lung and respiratory muscle function of patients with post-COVID-19 syndrome: a controlled and randomized study
Authors:
- Karina Vieira da CostaKCKarina Vieira da Costa
- Ewerton Graziane Gomes dos SantosESEwerton Graziane Gomes dos Santos
- Iara Tainá Cordeiro de SouzaISIara Tainá Cordeiro de Souza
- Celso Brendo Furtado BrandãoCBCelso Brendo Furtado Brandão
- João Victor dos Santos FelixJFJoão Victor dos Santos Felix
- Andressa Bomfim Lugon FaveroAFAndressa Bomfim Lugon Favero
- Dyego Tavares de LimaDLDyego Tavares de Lima
- Geraldo Eduardo Guedes de BritoGBGeraldo Eduardo Guedes de Brito
- Tatiana Onofre GamaTGTatiana Onofre Gama
- José Heriston de Morais LimaJLJosé Heriston de Morais Lima
- Rafaela PedrosaRPRafaela Pedrosa
- Eduardo Eriko Tenório de FrançaEFEduardo Eriko Tenório de França
Open Access
- 1 July 2024
- journal article
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 21 (7) , e6013
Abstract
Purpose: Thus, this study aimed to evaluate the effects of cardiopulmonary rehabilitation on lung and respiratory muscle function of patients with post-COVID-19 syndrome. Patients and methods: We conducted a randomized controlled trial with 34 patients with post-COVID-19 syndrome (> 18 years) who were symptomatic for more than four weeks. The evaluators were blinded. Participants were randomized into two groups: cardiopulmonary rehabilitation group or biweekly lectures (control group) regarding health education. We assessed lung function (forced vital capacity [FVC], forced expiratory volume in the first second [FEV1], FEV1/FVC ratio, and peak expiratory flow [PEF]), respiratory muscle strength and endurance, diaphragmatic thickening fraction and mobility, and dyspnea (modified Borg scale). Results: The intervention improved FVC, FEV1, and PEF of patients after six weeks of rehabilitation. The rehabilitation group also showed lower dyspnea and respiratory muscle strength and endurance than the control group. Conclusion: The cardiopulmonary rehabilitation protocol improved lung and respiratory muscle function and reduced dyspnea in patients with post-COVID-19 syndrome.Keywords
This publication has 29 references indexed in Scilit:
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysisScientific Reports, 2021
- Diaphragm dysfunction in severe COVID‐19 as determined by neuromuscular ultrasoundAnnals of Clinical and Translational Neurology, 2021
- 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective studyThe Lancet Respiratory Medicine, 2021
- Lung, Heart, Vascular, and Diaphragm Ultrasound Examination of COVID-19 Patients: A Comprehensive ApproachJournal of Cardiothoracic and Vascular Anesthesia, 2021
- Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized SituationThe American Journal of Medicine, 2020
- Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled studyComplementary Therapies in Clinical Practice, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysisTravel Medicine and Infectious Disease, 2020
- Diaphragmatic dysfunctionPulmonology, 2019
- Inspiratory muscle strength, diaphragmatic mobility, and body composition in chronic obstructive pulmonary diseasePhysiotherapy Research International, 2019